Yearly Archives: 2026
Kolosis BIO® Expands Surgical Biologics Portfolio with Launch of APEXecm™
The addition of APEXecm reflects Kolosis’s continued commitment to developing and commercializing best-in-class solutions for the surgical community
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved companion diagnostic for Zejula in the U.S.
Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent
New Resilience™ deployment system, anti-migration stent design, and unique stent sizes offer physicians control while enhancing treatment for patients with esophageal fistulas and malignant strictures
Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease
For Fabry patients, a potential path to converting 130 clinic visits into one treatment every five years.
BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
New results demonstrate early VOXZOGO treatment leads to durable and sustained improvements in skeletal growth-related health outcomes, including proportionality, arm span and body mass index, building on over 10,000 patient-years of data
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Springboard Enterprises Announces 2026 Women’s Health Accelerator Cohort
Women-led companies join Springboard’s accelerator to advance innovation across the women’s health landscape.
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’
Utah’s Life Sciences Community Takes Off at the 2026 Entrepreneur & Investor Summit
The 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit) served as a launchpad for innovation
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
Myriad Commercially Launches Precise MRD with Select Community Oncologists
Launch Represents Significant Step to Broader Commercialization
RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox
RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox
